 RESEARCH TRIANGLE PARK, N.C., Sept. 07, 2022 GLOBE NEWSWIRE -- G1 Therapeutics, Inc. Nasdaq: GTHX, a commercial-stage oncology company, today announced that Jack Bailey, G1s Chief Executive Officer, and other members of the executive team will participate virtually in the H.C. Wainwright 24th Annual Global Investment Conference. The fireside chat with G1 will be available at 7:00AM ET on September 12, 2022. The webcast and replay of this event will be accessible on the Events Presentations page of 